Voyageur Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Mar '26 Mar 9, 2026	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2019 - 2015
Market Capitalization	27	9	5	8	9	3	Upgrade
Market Cap Growth	-7.24%	70.79%	-33.85%	-12.43%	221.01%	-41.95%	Upgrade
Enterprise Value	26	9	5	8	8	3	Upgrade
Last Close Price	0.15	0.07	0.04	0.07	0.09	0.04	Upgrade
PB Ratio	18.57	20.15	3.70	5.48	4.81	9.32	Upgrade
P/TBV Ratio	18.57	20.15	3.70	5.48	4.81	9.32	Upgrade
Debt / Equity Ratio	0.03	0.13	0.03	0.02	0.02	0.88	Upgrade
Net Debt / Equity Ratio	-0.63	-0.25	0.02	-0.01	-0.41	0.87	Upgrade
Net Debt / EBITDA Ratio	0.36	0.07	-0.03	0.01	0.40	-0.27	Upgrade
Net Debt / FCF Ratio	0.34	0.24	-0.03	0.01	0.37	-0.61	Upgrade
Quick Ratio	0.49	0.11	0.06	0.10	1.39	0.02	Upgrade
Current Ratio	0.58	0.17	0.13	0.27	1.43	0.03	Upgrade
Return on Equity (ROE)	-261.78%	-181.07%	-96.50%	-104.07%	-185.44%	-214.90%	Upgrade
Return on Assets (ROA)	-52.14%	-39.76%	-35.90%	-43.03%	-64.23%	-49.37%	Upgrade
Return on Capital Employed (ROCE)	-167.60%	-300.60%	-82.10%	-106.70%	-101.50%	-311.90%	Upgrade
Earnings Yield	-11.67%	-18.83%	-26.36%	-21.86%	-22.39%	-39.91%	Upgrade
FCF Yield	-10.10%	-5.17%	-21.97%	-24.94%	-22.77%	-15.21%	Upgrade
Buyback Yield / Dilution	-14.68%	-5.46%	-21.03%	-13.89%	-34.24%	-22.58%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.